BiotechTube
Home/Pipeline/Therapeutic Biologics/VHH

Therapeutic Biologics/VHH

Not Specified

Pre-clinicalActive

Key Facts

Indication
Not Specified
Phase
Pre-clinical
Status
Active
Company
Phenotypeca

About Phenotypeca

Phenotypeca is a private, platform-based biotechnology company developing optimized yeast strains for recombinant protein manufacturing. Its patented QTL (Quantitative Trait Locus) strain optimization technology uses large-scale breeding and whole-genome screening to evolve strains with superior yield, stability, and processing characteristics. The company generates revenue by licensing ready-to-scale strains for biosimilars and peptides, and by providing custom strain engineering services to partners. It appears to be in an early-revenue stage, supported by project work including a grant from the Bill & Melinda Gates Foundation.

View full company profile

Therapeutic Areas

MetabolicOncologyInfectious DiseaseDermatology

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved